Pociredir (FTX-6058) is a potent and orally active inhibitor of Embryonic Ectoderm Development (EED) . Pociredir can induce HbF protein expression in cell and murine models. Pociredir can be used for the research of select hemoglobinopathies, including sickle cell disease and β-thalassemia[1][2].